Literature DB >> 8572428

Direct demonstration of radiolabeled von Willebrand factor binding to platelet glycoprotein Ib and IIb-IIIa in the presence of shear stress.

J K McCrary1, L H Nolasco, J D Hellums, M H Kroll, N A Turner, J L Moake.   

Abstract

In this study it is demonstrated for the first time that shear stress induces the binding of exogenous von Willebrand factor (vWF) multimers to platelets. The vWF preparations used were: 125I-vWF purified from human cryoprecipitate (and including all vWF multimers present in normal plasma); and 35S-cysteine-vWF secreted by human umbilical vein endothelial cells (HUVECs) (and containing unusually large vWF forms, as well as all plasma-type vWF multimers). Direct shear-induced binding to washed platelets (300-360 x 10(3)/microliters) of radiolabeled vWF was maximum at 60-120 dynes/cm2 evaluated at 30 sec and was in extent about one-quarter of the binding stimulated by ristocetin after 3 min of incubation. The shear-induced binding of only a small percentage of added radiolabeled vWF was sufficient to initiate aggregation. Radiolabeled vWF attached to both glycoprotein (GP) Ib and GPIIb-IIIa receptors in the shear field, with complete inhibition of binding occurring with simultaneous blockade of both receptors. Binding was potentiated by ADP released from sheared platelets.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8572428     DOI: 10.1007/bf02584477

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  21 in total

1.  Functional modulation of the isolated glycoprotein Ib binding domain of von Willebrand factor expressed in Escherichia coli.

Authors:  M Sugimoto; G Ricca; M E Hrinda; A B Schreiber; G H Searfoss; E Bottini; Z M Ruggeri
Journal:  Biochemistry       Date:  1991-05-28       Impact factor: 3.162

2.  Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors.

Authors:  R Pytela; M D Pierschbacher; M H Ginsberg; E F Plow; E Ruoslahti
Journal:  Science       Date:  1986-03-28       Impact factor: 47.728

3.  Characteristics of shear-induced aggregation in whole blood.

Authors:  C J Jen; L V McIntire
Journal:  J Lab Clin Med       Date:  1984-01

4.  Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization.

Authors:  F T Liu; J W Bohn; E L Ferry; H Yamamoto; C A Molinaro; L A Sherman; N R Klinman; D H Katz
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

5.  In vivo measurements of "apparent viscosity" and microvessel hematocrit in the mesentery of the cat.

Authors:  H H Lipowsky; S Usami; S Chien
Journal:  Microvasc Res       Date:  1980-05       Impact factor: 3.514

6.  Morphological, biochemical, and functional changes in human platelets subjected to shear stress.

Authors:  C H Brown; L B Leverett; C W Lewis; C P Alfrey; J D Hellums
Journal:  J Lab Clin Med       Date:  1975-09

7.  Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa.

Authors:  D M Peterson; N A Stathopoulos; T D Giorgio; J D Hellums; J L Moake
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

8.  Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.

Authors:  J L Moake; N A Turner; N A Stathopoulos; L H Nolasco; J D Hellums
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

9.  Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor.

Authors:  B S Coller; E I Peerschke; L E Scudder; C A Sullivan
Journal:  Blood       Date:  1983-01       Impact factor: 22.113

10.  Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin.

Authors:  J L Moake; N A Turner; N A Stathopoulos; L Nolasco; J D Hellums
Journal:  Blood       Date:  1988-05       Impact factor: 22.113

View more
  6 in total

Review 1.  Glycoprotein IIb/IIIa receptor inhibition in interventional cardiology.

Authors:  C M Gibson; J L Moynihan; E N Al-Mousa; M Campsey; R Gandhi; S Murphy; S Mattson; K A Ryan; R Mesley; J Swanson; M N Arshad; S J Marble
Journal:  J Thromb Thrombolysis       Date:  1999-06       Impact factor: 2.300

2.  High shear induces platelet dysfunction leading to enhanced thrombotic propensity and diminished hemostatic capacity.

Authors:  Zengsheng Chen; Nandan K Mondal; Shirong Zheng; Steven C Koenig; Mark S Slaughter; Bartley P Griffith; Zhongjun J Wu
Journal:  Platelets       Date:  2017-11-28       Impact factor: 3.862

3.  Computational fluid dynamics characterization of blood flow in central aorta to pulmonary artery connections: importance of shunt angulation as a determinant of shear stress-induced thrombosis.

Authors:  Carey Celestin; Martin Guillot; Nancy Ross-Ascuitto; Robert Ascuitto
Journal:  Pediatr Cardiol       Date:  2014-11-18       Impact factor: 1.655

4.  Computational study of pulsatile blood flow in prototype vessel geometries of coronary segments.

Authors:  A K Chaniotis; L Kaiktsis; D Katritsis; E Efstathopoulos; I Pantos; V Marmarellis
Journal:  Phys Med       Date:  2010-04-18       Impact factor: 2.685

5.  Combined blockade of ADP receptors and PI3-kinase p110β fully prevents platelet and leukocyte activation during hypothermic extracorporeal circulation.

Authors:  Stefanie Krajewski; Julia Kurz; Tobias Geisler; Karlheinz Peter; Hans Peter Wendel; Andreas Straub
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

6.  Models of Shear-Induced Platelet Activation and Numerical Implementation With Computational Fluid Dynamics Approaches.

Authors:  Dong Han; Jiafeng Zhang; Bartley P Griffith; Zhongjun J Wu
Journal:  J Biomech Eng       Date:  2022-04-01       Impact factor: 2.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.